Investor directory
Thuja Capital
Thuja Capital invests in early-stage life science companies in Europe, emphasizing transformative healthcare innovations.
What they invest in
Geographies
Europe
The facts
- Typical cheque
- €100k – €10M
- Headquarters
- Leiden, Netherlands
- Founded
- 2006
Selected portfolio
InnoSIGNFundaMental PharmaPan Cancer TIndigo (Monitoring Equipment)NutriLeadsATRO MedicalAstriVaxKinetyxEncareCytura TherapeuticsAlesta TherapeuticsAlveron PharmaArgenXArtica TherapeuticsAstrivax TherapeuticsAtro MedicalBioCerosBrandarisCardiacBoosterDC PrimeEsoBiotecFundamental PharmaGradient Denervation TechnologiesIndigo
and 10 more
Recent rounds
Salvia BioElectronics
€53MSeries BHealthTechInnovation IndustriesleadThuja CapitalInvest-NLInkefPanakès PartnersSHS Capital · +3 more in the source
Netherlandssiliconcanals.comAlveron Pharma
€5MSeedHealthTechBroadview VenturesleadThuja CapitalWaterman Ventures · +2 more in the source
Netherlandssiliconcanals.com
Rounds Thuja Capital took part in, as reported by the linked articles. See who else is investing right now.
Does Thuja Capital fit your round?
In 30 minutes you'll know which funds matter for your round.
Book a callAre you Thuja Capital? Tell us what to correct and we will update it — or ask us to remove the entry.